𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of malignant testicular tumors in childhood: Results of the german national study 1982–1992

✍ Scribed by Haas, Rainer J. ;Schmidt, Piroska ;Göbel, Ulrich ;Harms, Dieter


Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
501 KB
Volume
23
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The German Cooperative Protocol for treatment of testicular germ cell tumors in childhood registered 106 patients from January 1982 through February 1992. Sixty‐one patients suffered from yolk sac tumors (YST); 25 patients from differentiated teratomas (TD); 19 patients from malignant teratomas of either intermediate (MTI), undifferentiated (MTU), or trophoblastic type (MTT), and 1 patient from a seminoma.

A stratified chemotherapy based on stage and histology was administered in addition to unilateral orchiectomy: Standard chemotherapy consisted of four treatments with vinblastine, bleomycin, and cisplatinum. If viable tumor was suspected after two treatments with standard chemotherapy, a delayed explorative laparotomy was done. There were two options based on the histological findings: In case of complete tumor regression, the standard chemotherapy was continued. In case of incomplete tumor response, patients a salvage chemotherapy consisting of three treatments with VP 16 (etoposide), ifosfamide, and cisplatinum. In addition three injections with VP 16 were given as a maintenance therapy.

The following results were obtained: YST: 59 patients with stage I. Forty‐nine patients were followed according to “wait and see” policy. Eight of these needed a delayed standard chemotherapy. The relapse free survival of all 61 patients in 100%. Median observation time is 49 months.

TD: Twenty‐five patients had stage I. No chemotherapy was given. The relapse free survival is 100%. Median observation time is 48 months.

Malignant teratomas (MTI, MTU, MTT): 8 patients had stage I. Three of these adjuvant chemotherapy and 5 lymphadenectomy without chemotherapy. All patients survived without relapse. Nine patients had stage II and standard chemotherapy. Four of these patients had a delayed explorative laparotomy leading to a salvage therapy in two patients. All patients survived relapse free. Two patients had stage III. Of these 1 standard chemotherapy and is well. One patient suffering from MTU stage IIIA died due to candida septicemia during salvage therapy. Median observation time of the entire group is 60 months. © 1994 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Malignant germ cell tumors in childhood:
✍ Curto, Margherita Lo ;Lumia, Francesca ;Alaggio, Rita ;Cecchetto, Giovanni ;Alma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract ## Background and Aims About 20% of patients with germ cell tumor (GCT) are still resistant to therapy. To investigate which features are present in resistant patients, a multicenter study on GCT in children was undertaken to correlate clinical and laboratory parameters with the outcom

Ifosfamide/etoposide combination in the
✍ Faith H. Kung; Charles B. Pratt; Roger A. Vega; Norman Jaffe; Douglas Strother; 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB

Background. The prognosis for children with recurrent or resistant malignant solid tumors remains dismal. More effective rescue therapy is needed for these children. Methods. Between August 1987 and November 1990, 311 children with recurrent or resistant malignant solid tumors were treated by inves

Combination chemotherapy in malignant no
✍ U. Göbel; G. Calaminus; R. J. Haas; H. Jürgens; D. Niethammer; J. Ritter; H. J. 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 522 KB

In January 1983, the German Society of Pediatric Oncology started a cooperative trial (MAKEI 83) for non-testicular germ-cell tumors. The pilot phase closed in December 1985. The treatment regimen was stratified according to histology, tumor site and tumor stage. In malignant non-seminomatous germ-c

Comparison of outcomes based on treatmen
✍ David A. Rodeberg; James R. Anderson; Carola A. Arndt; Fernando A. Ferrer; Richa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 325 KB

## Abstract The purpose of this study was to determine patient characteristics and outcomes for bladder/prostate (BP) rhabdomyosarcoma (RMS) using an international cohort of prospectively treated patients comparing different treatment algorithms. Data were collected from 379 patients (1979–1998) tr